Market Newsdesk

ROCHESTER, NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) — Syntec Optics (Nasdaq: OPTX), a leading provider of mission-critical optics for defense tech, space tech, and AI data centers, today announced that the company more than doubled its purchase orders—worth over $9 million—to supply defense equipment, up from its Q1 announcement about orders for diverse defense platforms.

Orders for optics that help guide missiles to hit targets accurately grew an additional 30% since the last announcement of a 40% increase. On another front, Syntec continued to add orders for optics and optics-mechanicals used in equipment that helps soldiers see clearly in the dark and spot targets day or night. Orders for optics and opto-mechanicals for specialized lasers used for targeting and defense also grew.

Orders grew across all platforms. This ranged from advanced optics for night vision goggles that soldiers have used for nearly 10 years, to new augmented reality (AR) and mixed-reality headsets that use artificial intelligence (AI) to give soldiers a digital edge on the battlefield. 

Matt Carey, vice-president at Syntec, explained, “Winning these orders proves the company can build tough, reliable equipment that keeps soldiers and us safe and helps U.S. succeed on missions around the world.”

According to Morgan Stanley, increased defense spending in the U.S. is part of a broader movement in which geopolitical conflicts are catalyzing reinvestment and modernization efforts worldwide.

About Syntec Optics

Headquartered in Rochester, N.Y., Syntec Optics Holdings, Inc. (NASDAQ: OPTX) is one of the nation’s largest bespoke manufacturers of high-precision optics and photonics. With a dedicated team of nearly 180 employees, the company pushes the limits of light-based technologies to connect and protect the world. Syntec supports critical missions ranging from low-Earth-orbit satellites to advanced connected-battlefield defense platforms, AI data centers, and life sciences. As light-enabled technologies continue to account for a significant portion of global economic output—representing nearly $16 trillion of the $106 trillion in total worldwide production as of 2023—Syntec Optics remains positioned at the forefront of the modern optical revolution.

For more information, visit syntecoptics.com.

Forward-Looking Statements

This press release contains certain “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this press release, including statements as to the intended use of net proceeds from the public offering, are forward-looking statements. Some of these forward-looking statements can be identified by the use of forward-looking words, including “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” “plan,” “targets,” “projects,” “could,” “would,” “continue,” “forecast” or the negatives of these terms or variations of them or similar expressions. All forward-looking statements are subject to risks, uncertainties, and other factors (some of which are beyond the control of Syntec Optics), which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. All forward-looking statements are based upon estimates, forecasts and assumptions that, while considered reasonable by Syntec Optics and its management, as the case may be, are inherently uncertain and many factors may cause the actual results to differ materially from current expectations which include, but are not limited to: 1) risk outlined in any prior SEC filings; 2) ability of Syntec Optics to successfully increase market penetration into its target markets; 3) the addressable markets that Syntec Optics intends to target do not grow as expected; 4) the loss of any key executives; 5) the loss of any relationships with key suppliers including suppliers abroad; 6) the loss of any relationships with key customers; 7) the inability to protect Syntec Optics’ patents and other intellectual property; 8) the failure to successfully execute manufacturing of announced products in a timely manner or at all, or to scale to mass production; 9) costs related to any further business combination; 10) changes in applicable laws or regulations; 11) the possibility that Syntec Optics may be adversely affected by other economic, business and/or competitive factors; 12) Syntec Optics’ estimates of its growth and projected financial results for the future and meeting or satisfying the underlying assumptions with respect thereto; 13) the impact of any pandemic, including any mutations or variants thereof and the Russian/Ukrainian or Israeli conflict, and any resulting effect on business and financial conditions; 14) inability to complete any investments or borrowings in connection with any organic or inorganic growth; 15) the potential for events or circumstances that result in Syntec Optics’ failure to timely achieve the anticipated benefits of Syntec Optics’ customer arrangements; and 16) other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in prior SEC filings. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Syntec Optics does not give any assurance that Syntec Optics will achieve its expected results. Syntec Optics does not undertake any duty to update these forward-looking statements except as otherwise required by law.

For further information, please contact:

Investor Relations

[email protected] 

SOURCE: Syntec Optics Holdings, Inc. (Nasdaq: OPTX)

New Bobtail Expected to Generate Approximately AED 400,000 to AED 500,000 ($109,000 to $136,000) in Monthly Revenue Upon Reaching Target Delivery Volume

Al Shola Gas Expands Fleet to 53 Vehicles, Including Three LPG Bobtails, with Fourth Bobtail on Order to Support Further Distribution Growth

New Dubai Supreme Council of Energy Petroleum Products Permit Strengthens Al Shola Gas’s Competitive Position in Dubai’s LPG Market

Dublin, Ireland, Sept. 10, 2026 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), a diversified energy platform, today announced that its indirect subsidiary, Al Shola Al Modea Gas Distribution L.L.C. (“Al Shola Gas”), an industrial liquefied petroleum gas (“LPG”) engineering and distribution company with operations in the United Arab Emirates (“UAE”), has taken delivery of a new liquefied petroleum gas (“LPG”) bobtail tanker, expected to generate approximately AED 6.0 million ($1.6 million) in annual recurring revenue once its target delivery run-rate is achieved and sustained.

The addition represents another step in the expansion of Al Shola Gas’s recurring LPG distribution business in the United Arab Emirates (“UAE”). The new bobtail increases Al Shola Gas’s fleet to 53 vehicles, including three LPG bobtails and 10 LPG cylinder trucks.

Al Shola Gas expects the newly delivered bobtail to progressively ramp to approximately 200 metric tons of LPG deliveries per month within four to six months of entering service. At that target volume, the Company expects the unit to generate approximately AED 400,000 to AED 500,000 ($109,000 to $136,000) in monthly revenue, equivalent to approximately AED 1.2 million to AED 1.5 million ($327,000 to $408,000) in quarterly revenue and approximately AED 6.0 million ($1.6 million) in annual recurring revenue at the upper end of the targeted monthly revenue range.

The targeted delivery volume is supported by the performance of Al Shola Gas’s existing bobtail fleet. Its larger-capacity bobtail currently delivers approximately 450 metric tons of LPG per month, while an existing bobtail comparable in capacity to the newly delivered unit currently delivers approximately 250 to 325 metric tons per month. The new bobtail has an approximately 17,800-liter LPG capacity and is expected to operate approximately 10 to 12 hours per day, seven days per week. Beyond adding incremental revenue capacity, the new unit is expected to improve delivery reliability and reduce Al Shola Gas’s reliance on third-party competitors when existing vehicles are unavailable due to scheduled maintenance or unexpected downtime.

Al Shola Gas also plans to expand its distribution capabilities through an additional LPG bobtail, which is currently in production. The approximately 7,000-liter unit is being built on a smaller chassis specifically designed to serve customers in city centers and other congested locations where larger LPG tankers face access, maneuverability and parking limitations. The smaller-format bobtail is expected to expand the range of customers and locations Al Shola Gas can economically serve, complementing the Company’s larger-capacity units and providing additional flexibility as it seeks to grow its LPG distribution business. Together, the new and planned bobtails are designed to increase Al Shola Gas’s delivery capacity, improve fleet redundancy and broaden its addressable customer base.

Separately, Al Shola Gas has obtained a Petroleum Products Permit from the Dubai Supreme Council of Energy (“SCE”), authorizing continued gas cylinder distribution, transport, sale and storage, as well as the bulk transport, distribution and sale of LPG via tanker. Under Dubai’s Executive Council Resolution No. 85 of 2025, all persons engaged in petroleum products trading activities in Dubai, including the distribution, transport, sale and storage of LPG, are required to hold a valid Petroleum Products Permit issued by the SCE, positioning Al Shola Gas to pursue LPG distribution opportunities, including tenders, that require such authorization.

Al Shola Gas’s permitting process took more than eight months to complete. Fusion Fuel believes the combination of increasingly rigorous Petroleum Products Permit requirements and enhanced enforcement measures under Dubai’s regulatory framework could reduce the number of non-compliant operators participating in the Dubai LPG market and create additional opportunities for fully permitted operators such as Al Shola Gas.

Frederico Figueira de Chaves, Chief Executive Officer of Fusion Fuel, commented, “The delivery of this new bobtail is a tangible example of how we are investing in assets that can translate directly into additional recurring revenue. At target run-rate, this single unit is expected to generate approximately $1.6 million in annual recurring revenue, while also increasing delivery reliability and reducing our reliance on third parties. Importantly, we are not stopping here. A fourth, smaller-format bobtail is on order and is designed to expand our ability to serve customers in locations that are difficult to access with larger vehicles.

“We believe Al Shola Gas’s new Petroleum Products Permit will provide another important competitive advantage as Dubai moves toward stricter enforcement across the LPG industry. As a fully permitted operator, we believe Al Shola Gas is well positioned to pursue additional tenders and distribution opportunities as the regulatory framework continues to mature. The combination of additional revenue-generating capacity, an expanding fleet and a strengthened regulatory position supports our strategy of growing Fusion Fuel’s recurring, cash-generative energy businesses in the UAE.”

About Fusion Fuel Green PLC

Fusion Fuel Green PLC (Nasdaq: HTOO) is a diversified energy platform offering a comprehensive suite of energy supply, distribution, and engineering and advisory solutions through its operating businesses Al Shola Gas, Bright Hydrogen Solutions Ltd (“BrightHy Solutions”) and Biosteam Energy (Proprietary) Limited (“BioSteam Energy”). Al Shola Gas provides full-service industrial LPG solutions, including the design, supply, and maintenance of LPG systems, as well as the transport and distribution of LPG across commercial, industrial, and residential sectors. BrightHy Solutions, the Company’s hydrogen solutions platform, delivers engineering and advisory services enabling decarbonization across hard-to-abate industries. BioSteam Energy provides biomass-powered industrial steam solutions to clients. Through Royal Uranium Inc., the Company also holds a portfolio of uranium and natural gas royalty and other interests across Canada, Colombia and Argentina. For more information, please visit www.fusion-fuel.eu.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or the Company’s future financial or operating performance and can be identified by words such as “may,” “will,” “believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “should,” “seeks,” “future,” “continue,” “plan,” “target,” “predict,” “potential,” or the negative of such terms, or other comparable terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding: the expectation that the new bobtail tanker will reach a target monthly delivery volume of approximately 200 metric tons of LPG within four to six months of entering service; the expectation that the new bobtail will generate approximately AED 400,000 to AED 500,000 ($109,000 to $136,000) in monthly revenue, approximately AED 1.2 million to AED 1.5 million ($327,000 to $408,000) in quarterly revenue, and approximately AED 6.0 million ($1.6 million) in annual recurring revenue once its target volume is reached and sustained; the anticipated timeline for the new bobtail to reach its target delivery volume; the performance of Al Shola Gas’s existing bobtail fleet as an indicator of the new unit’s potential; the expected benefits of Al Shola Gas’s Petroleum Products Permit, including its effect on competitive positioning and the ability to pursue tenders and other distribution opportunities; the belief that increasingly rigorous Petroleum Products Permit requirements and enhanced enforcement under Dubai’s regulatory framework could reduce the number of non-compliant operators and create additional opportunities for fully permitted operators; the anticipated benefits of the bobtail currently in production, including the ability to serve customers in locations that are difficult to access with larger vehicles; the believed competitive advantage of obtaining a Petroleum Products Permit from stricter enforcement of regulatory requirements in the LPG industry; and the Company’s strategy of growing recurring, cash-generative energy businesses in the UAE. These forward-looking statements are based on current expectations and assumptions and are not guarantees of future performance, conditions, or results. They involve known and unknown risks, uncertainties, and other important factors, many of which are outside the Company’s control, that could cause actual results to differ materially from those expressed or implied, including, without limitation: geopolitical instability or armed conflict in the Middle East region that could disrupt Al Shola Gas’s operations in the UAE; the Company’s ability to support the expansion of the operations of Al Shola Gas; the risk that the new bobtail does not achieve its targeted delivery volumes or revenue within the anticipated timeframe or at all; fluctuations in demand for LPG distribution services; the risk that anticipated regulatory tightening, enforcement actions, or market consolidation in Dubai’s LPG distribution market does not occur as expected or does not benefit fully permitted operators such as Al Shola Gas; regulatory changes affecting LPG distribution and engineering services in the UAE, including the risk that Al Shola Gas’s permits are not renewed or are revoked; the risk that the bobtail in production is not completed, delivered, or deployed as anticipated, or does not achieve expected operational or revenue benefits; volatility in energy markets and commodity prices; Al Shola Gas’s ability to obtain sufficient financing to support operations and growth initiatives; competition from existing or new LPG distributors in Dubai; risks related to foreign exchange, including the potential for adjustment of the AED/USD exchange rate that could reduce the U.S. dollar value of the contemplated revenue; risks associated with operating internationally, including in the UAE; and the risks and uncertainties described in Exhibit 99.2 to the Report on Form 6-K/A furnished by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on July 29, 2026, the Company’s Annual Report on Form 20-F filed with the SEC on May 7, 2026, and other filings with the SEC. Actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. All forward-looking statements in this press release are qualified in their entirety by the cautionary statements above. The Company does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances that may arise after the date hereof, except as required by law.

Investor Relations Contact:

[email protected]

www.fusion-fuel.eu

SANTA ANA, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”) announced today that it intends to offer, subject to market and other customary conditions, $500 million in aggregate principal amount of senior notes due 2034 (the “Notes”) in a private offering exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). The Notes will be senior unsecured obligations of TTM and will be guaranteed by TTM’s subsidiaries that guarantee its senior secured credit facilities, including its term loan B due 2030 and its revolving credit facility (the “Revolving Credit Facility”), subject to certain exceptions.

TTM intends to use the net proceeds of the offering of the Notes, together with expected borrowings from a $300 million incremental senior secured term loan A and a $800 million incremental senior secured term loan B (collectively, the “Incremental Facilities”), to fund the purchase price for the previously announced proposed acquisition of EDS Intermediate Holding, LLC (“Epiq Solutions”), for general corporate purposes, which may include the reduction of any amounts TTM may borrow under the Revolving Credit Facility to fund the purchase price for the previously announced proposed acquisition of Swiss Technology Group AG (“STG”), and to pay related fees and expenses.

The offering of the Notes is not conditioned on the consummation of the proposed acquisition of Epiq Solutions, and the consummation of the proposed acquisition of Epiq Solutions is not conditioned upon the closing of the offering of the Notes. If the acquisition of Epiq Solutions is not consummated on or before November 15, 2026 (subject to automatic extension to May 15, 2027 in certain circumstances) (the “Outside Date”) or TTM delivers a notice in writing to the trustee stating that it has determined that the consummation of the acquisition of Epiq Solutions will not occur on or before the Outside Date, TTM will be required to redeem the Notes at a redemption price equal to 100% of the principal amount thereof, plus accrued and unpaid interest from the issuance date of the Notes to, but excluding, the redemption date.

The Notes and the related guarantees are being offered solely to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act or outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act. The Notes and the related guarantees have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities or blue sky laws and foreign securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any Notes, nor shall there be any sales of the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This press release is being issued pursuant to, and in accordance with, Rule 135c under the Securities Act.

Forward-looking Statements

This release contains forward-looking statements that relate to future events. TTM cautions you that such statements are simply predictions and actual events or results may differ materially. These statements reflect TTM’s current expectations, and TTM does not undertake to update or revise these forward-looking statements, even if experience or future changes make it clear that any projected results expressed or implied in this or other TTM statements will not be realized. Further, these statements involve risks and uncertainties, many of which are beyond TTM’s control, which could cause actual results to differ materially from the forward-looking statements. Statements related to, among other things, the consummation of the offering of the Notes, the consummation of the Incremental Facilities, TTM’s ability to successfully consummate the proposed acquisition of Epiq Solutions, and potential changes in market conditions constitute forward-looking statements. For a description of additional factors that may cause TTM’s actual results, performance or expectations to differ from any forward-looking statements, please review the information set forth in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of TTM’s public reports filed with the Securities and Exchange Commission.

About TTM

TTM Technologies, Inc. is a leading global manufacturer of technology products, including mission systems, radio frequency (“RF”) components, RF microwave/microelectronic assemblies, and technologically advanced interconnect products, including printed circuit boards and substrates. TTM stands for time-to-market, representing how TTM’s time-critical, one-stop design, engineering and manufacturing services enable customers to reduce the time required to develop new products and bring them to market.

Contact:

Sean K.F. Hannan,
Vice President, Investor Relations
[email protected]
+1 339 466 7737

Authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) builds on CAMP4’s recent clearances to initiate first-in-human studies for CMP-002 in Australia and Argentina

Company anticipates initiation of the clinical trial in 4Q 2026

WATERTOWN, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) — CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced the company has received authorization from the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) to include UK sites in the Company’s global Phase 1/2 clinical trial of CMP-002, a potential first-in-class, disease-modifying therapeutic candidate for patients with SYNGAP1-related disorder.

“This authorization by the MHRA expands the reach of our Phase 1/2 clinical trial and reinforces our commitment to rapidly advancing CMP-002 for patients and their families who have been without an intervention that tackles the underlying drivers of this disease,” said Josh Mandel-Brehm, President and Chief Executive Officer of CAMP4. “This milestone builds on the regulatory momentum we established with recent clearances in Australia and Argentina, and we remain on track to initiate the study during the fourth quarter of 2026.”

In July 2026, the company received clearance to initiate the Phase 1/2 clinical trial from Australia’s Therapeutic Goods Administration (TGA) and local Human Research Ethics Committee (HREC), as well as Argentina’s Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT), supporting initiation of a Phase 1/2 clinical trial of CMP-002 in Q4 2026. The company has also submitted regulatory filings in the European Union, which remain under review.

About SYNGAP1-Related Disorder

SYNGAP1-related disorder (also referred to as SYNGAP1) is a rare, haploinsufficient CNS disorder caused by mutations in the SYNGAP1 gene, resulting in approximately 50% of normal SYNGAP protein levels. The condition affects over 10,000 individuals in the United States and is characterized by intellectual disability in 100% of patients, epilepsy in approximately 85%, severe behavioral problems in approximately 70%, sleep problems in approximately 60%, and limited communication, with approximately 30% of patients being non-verbal. There are currently no approved disease-modifying therapies for patients living with SYNGAP1.

About CMP-002

CMP-002 is CAMP4’s lead investigational antisense oligonucleotide (ASO) therapeutic candidate designed to bind to a SYNGAP1-specific regRNA to increase SYNGAP1 gene expression and restore SYNGAP protein toward near wild-type levels. Administered intrathecally, CMP-002 has demonstrated dose-dependent increases in SYNGAP protein expression in patient-derived neurons, reversal of disease-relevant behavioral phenotypes in a humanized haploinsufficient mouse model, statistically significant improvement of seizure phenotypes and parameters in a chemically induced seizure mouse model, and broad brain distribution with significant SYNGAP protein upregulation in non-human primates.

About CAMP4 Therapeutics

CAMP4 is developing disease-modifying treatments for a broad range of genetic diseases where amplifying healthy protein may offer therapeutic benefits. Our approach amplifies mRNA by harnessing a fundamental mechanism of how genes are controlled. To amplify mRNA, our therapeutic ASO drug candidates target regulatory RNAs (regRNAs), which act locally on transcription factors and are the master regulators of gene expression. CAMP4’s proprietary RAP Platform^® enables the mapping of regRNAs and generation of therapeutic candidates designed to target the regRNAs associated with genes underlying haploinsufficient and recessive partial loss-of-function disorders, of which there are more than 1,200, in which a modest increase in protein expression may have the potential to be clinically meaningful. For more information, visit camp4tx.com.

Forward-Looking Statements

This press release contains forward-looking statements which involve risks, uncertainties and contingencies, many of which are beyond the control of the Company, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. All statements other than statements of historical facts contained in this press release are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements include, but are not limited to, statements concerning the anticipated timeline for initiation of the Company’s planned Phase 1/2 clinical trial of CMP-002 in patients with SYNGAP1-related disorder; the therapeutic potential and intended mechanism of action of CMP-002; the potential of the Company’s RAP Platform technology; the expected outcome of the Company’s pending regulatory submissions in other jurisdictions; the Company’s ability to satisfy the conditions of regulatory authorizations received to date; and the Company’s strategy, goals, business plans and focus. The forward-looking statements in this press release speak only as of the date of this press release and are subject to a number of known and unknown risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially from those anticipated in the forward-looking statements, including, but not limited to: the Company’s limited operating history, incurrence of substantial losses since inception and anticipated incurrence of substantial and increasing losses for the foreseeable future; the Company’s need for substantial additional financing to achieve its goals; the uncertainty of clinical development and risks related to additional costs or delays in the development and commercialization of the Company’s product candidates; delays or difficulties in the enrollment and dosing of patients in clinical trials; the impact of any significant adverse events or undesirable side effects caused by the Company’s product candidates; potential competition, including from large and specialty pharmaceutical and biotechnology companies; the Company’s ability to realize the benefits of the Company’s current or future collaborations or licensing arrangements and ability to successfully consummate future partnerships; the Company’s ability to manage the Company’s growth and expansion of the Company’s operations; risks related to the manufacturing of the Company’s product candidates; the Company’s ability to obtain and maintain sufficient intellectual property protection for its product candidates; the Company’s reliance on third parties to conduct the Company’s preclinical studies and clinical trials; the Company’s compliance with the Company’s obligations under the licenses granted to the Company by others for the rights to develop and commercialize the Company’s product candidates; risks related to the operations of the Company’s suppliers; and other risks and uncertainties described in the section “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, as well as other information the Company files with the Securities and Exchange Commission. The forward-looking statements in this press release are inherently uncertain and are not guarantees of future events. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond the Company’s control, you should not unduly rely on these forward-looking statements. The events and circumstances reflected in the forward-looking statements may not be achieved or occur and actual future results, levels of activity, performance and events and circumstances could differ materially from those projected in the forward-looking statements. Moreover, the Company operates in an evolving environment. New risks and uncertainties may emerge from time to time, and management cannot predict all risks and uncertainties. Investors, potential investors, and others should give careful consideration to these risks and uncertainties. Except as required by applicable law, the Company does not undertake to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Contacts

Investor Relations:

Sara Michelmore
Milestone Advisors
[email protected]

Media:

Sofia Bermudez
LifeSci Communications
[email protected]

In the Past 5 Years Deako Has Shipped Over 32 million Units of Its Technologies Including Its Smart Home Plug-In Wall Switches, with Over $26M in Revenues in 2025 

Deako is a Leading Technology Supplier to Over 50 U.S. Builders Including D.R. Horton, Toll Brothers,
Risewell Homes,
Adams Homes, Maronda Homes,
Shea Homes, Schumacher Homes,
Among Others, and is Expected to Fast Track SKYX’s Technologies to the Vast Builder Market

Deako’s Lead Investor and Board Member, Include Paul Jacobs, former Chairman and CEO of Qualcomm, and Board Member Marwan Fawaz, former CEO of Nest

SKYX and Deako Management will Hold a Conference Call Today, September 10, 2026, at 8:30 a.m. Eastern Time, to Discuss Merger Aspects. See below for dial-in information.

MIAMI, Sept. 10, 2026 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), an award winning highly disruptive advanced safe-smart home and AI platform technology company with over 100 U.S. and global pending and issued patents and a portfolio of 60 lighting and home décor websites, with a mission to make homes and buildings become advanced, safe and smart instantly as the new standard, today announced it has signed a merger agreement with U.S. AI smart home Silicon Valley backed company Deako Inc., aiming to lead the AI smart home, builder and hotel markets with their combined plug and play smart home and AI platform technologies.

Merger Agreement Highlights and Economics

• Deako Inc. is a smart home AI platform and intelligent lighting company with 20 U.S. and global patents and patent pending applications for plug & play advanced, smart home and AI activated lighting wall switches.
• The merger agreement between SKYX and Deako will enable SKYX to address from A-to-Z the smart electronic real estate of electrical outlet boxes in homes and buildings including wall outlets, wall switches and ceiling outlet boxes for smart home and safety products, lighting, ceiling fans, smoke detectors, among others, all with advanced and smart home plug & play solutions.
• Most smart home solutions today require time-consuming and costly wired installation and address only part of the A-to-Z opportunity, while the SKYX Deako merger is aiming to facilitate an entire A-to-Z solution, all plug & play for advanced, smart home AI platforms and products.
• Based on SKYX technology’s safety aspects, during the past years its safe instant plug & play ceiling outlet receptacle system has received vote approvals from U.S. leading building safety standardization organizations including 10 segments in the NFPA-NEC code book (National Fire Protection Association / National Electrical Code) and its technology’s specifications received an approval vote by ANSI/NEMA as a standard.
• In the past 5 years Deako has shipped over 32 million units of its technologies including its smart home plug-in wall switches, with over $26 million in revenue in 2025.
• Deako is a leading technology supplier to the builder market with over 50 U.S. builders, including D.R. Horton, Toll Brothers, Risewell Homes, Adams Homes, Maronda Homes, Shea Homes, Schumacher Homes, among others.
• The merger is expected to fast track SKYX’s technologies and products into Deako’s vast builder market footprint of over 50 U.S. builders, including those named above. Additionally, the merger will open the door for Deako’s products into SKYX projects including Marriott and European hotels, Miami’s $4 billion Smart City, among others.
• The SKYX Deako merger is expected to increase Deako’s SKU count to the builder, hotel and pro markets five-fold.
• Why are all cars smart while 90% of homes are not? The main reason and barrier are the complexity, time consuming, costly and rigorous wiring installation. The SKYX Deako merger provides an instant smart home safe plug & play solution for homes, buildings, hotels among others.
• The merger is expected to provide deployment opportunities of millions of combined products into the builder, hotel and pro market and future recurring revenue opportunities from plug & play product interchangeability, AI services, monitoring, subscriptions, licensing, among others.
• The merger will enable significant cost saving synergies including overhead consolidation in software, accounting, general administration, sourcing, efficiency optimization and other benefits.
• Deako’s Founder and CEO is Derek Richardson, former sales leader in prominent tech companies Blackberry and Cypress. Derek will remain CEO of Deako and will lead SKYX’s growth including to the builder, hotel, and pro markets.
• Deako’s Board members include Paul Jacobs (former Qualcomm Chairman and CEO), Marwan Fawaz (former CEO of Nest), and Executive Chairman, Scott Vertrees.
• As consideration for the merger SKYX will issue common stock, equal to 18.46% of the Company, totaling 25,000,000 shares subject to up to a 2-year lockup/leak out agreement (1-year full lock up, in addition to 9-12 months leak out) with Rule 10b5-1 trading plan.
• Post merger, current SKYX’s shareholders will own 84.4% of the Company and Deako’s shareholders and lender collectively will own 15.6%.
• In addition, SKYX will pay Deako’s lender a payment of $4M by closing and issue a note of $8.5M, with $2.25M paid in Q-1 2027, and the remaining $6.25M in Q-4 2027.
• The merger will expand the collective patent portfolio where SKYX has over 100 patents and pending applications and Deako with 20 patents and patent pending applications to over 120 patents and patent pending applications, related to platforms, smart home, AI and plug & play products.

Paul Jacobs, Deako Board Member, former Chairman and CEO of Qualcomm, said: “Throughout my career, I have been deeply involved in building ecosystems and platforms to integrate diverse capabilities into smartphones and other devices. The merger of SKYX Platforms and Deako brings together two synergistic platforms for the home. To date, the smart home has advanced slowly device by device. SKYX combines its position at the ceiling, its all-in-one smart home hub and AI platform and its safe plug & play ceiling outlet receptacle, with Deako’s wall receptacle, intelligent switches and more than 32 million products already shipped into homes. Together they provide the electronic real estate of homes, buildings and hotels, where power, control, sensing and AI intelligence will naturally live. This merger can drive the new standard for safe, smart and AI intelligent homes.”

Marwan Fawaz, Deako Board Member and former CEO of Nest, said: “Smart home solutions have historically been overly complicated to bring to market; they need an easier and more intuitive consumer experience. The combination of SKYX and Deako provides a broad array of products to solve these complex and challenging problems in the home with innovation, simplicity, and safety in mind. Going forward, the combined companies will work in tandem with the large technology/AI providers to capitalize on the tsunami of innovation coming to the intelligent home experience.”

Steve Schmidt, President of SKYX and former CEO of A.C. Nielsen, said: “We are excited about the SKYX Deako merger. I strongly believe that our combined plug & play platform technologies with vast electronic real estate and endless offerings including home safety sensors, smart home sensors, AI intelligence and much more will be game-changing for the smart home, building and hotel industries. Working with Rani for many years, I would emphasize that this merger and its growth potential really demonstrate how Rani’s vision, and business acumen are as unique as his inventing capabilities.”

Derek Richardson, CEO and Founder of Deako Inc., said: “We are very excited for our merger with SKYX and its game-changing platform technologies, including its all-in-one smart home and AI platform technology, as well as its plug & play ceiling outlet receptacle platform that was voted by ANSI / NEMA and NFPA – NEC based on its significant safety aspects. The smart home is won or lost at the moment a house is being built — that’s why we built Deako for the builder channel first. As the intelligent home emerges, the electronic real estate inside a house becomes critical infrastructure, and the ceiling and the wall are everything. Joining SKYX pairs what we’ve built at the wall with what they’ve built at the ceiling that maximizes performance of smart home products and gives builders one complete, plug-and-play solution instead of a collection of parts.”

Rani Kohen, Founder and Executive Chairman of SKYX Platforms, said: We are very excited for our merger with Deako and its team members. We strongly believe that the SKYX Deako combined platform technologies, patent portfolio, and collective teams, will significantly grow our market penetration in the builder, hotel and pro market and will offer future additional recuring revenue opportunities from plug & play product upgrades, AI services, monitoring, subscriptions, licensing, among others. The SKYX-Deako merger and its terms provide tremendous value validation of our technologies, including our vast global patent portfolio and our safety-related building code approvals by NFPA-NEC and ANSI/NEMA, while also delivering significant value to our shareholders.

For more information about Deako: Click Here

For a video demo of SKYX’s technologies: Click Here

Dial In Information

Participating Management

SKYX Representatives
Deako Representatives

Conference Call and Webcast Details

Date: Thursday, September 10, 2026
Time: 8:30 a.m. Eastern Time
U.S. dial-in: 1-877-407-0792
International dial-in: 1-201-689-8263
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1775971&tp_key=18e7862478

Participants should connect approximately 10 minutes before the scheduled start Participant Listening: 1-877-407-0792 or 1-201-689-8263

Call me™: 

https://callme.viavid.com/viavid/?callme=true&passcode=13760591&h=true&info=company&r=true&B=6

– Participants can use Guest dial-in #s above and be answered by an operator OR click the Call me™ link for instant telephone access to the event.
– Call me™ link will be made active 15 minutes prior to scheduled start time.

Telephone replay

A telephone replay will be available approximately three hours after the call through October 10, 2026, at 11:59 p.m. Eastern Time.

U.S. replay dial-in: 1-844-512-2921
International replay dial-in: 1-412-317-6671
Replay access ID: 13762632

About SKYX Platforms Corp.

As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced, safe, smart and AI platform technologies, with over 100 U.S. and global patents and patent pending applications. Additionally, the Company owns 60 lighting and home décor websites for both retail and commercial segments. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://www.skyx.com/ or follow us on LinkedIn.

Forward-Looking Statements

Certain statements made in this press release are not based on historical facts, but are forward-looking statements. These statements can be identified by the use of forward-looking terminology such as “aim,” “anticipate,” “believe,” “can,” “could,” “continue,” “estimate,” “expect,” “evaluate,” “forecast,” “guidance,” “intend,” “likely,” “may,” “might,” “objective,” “ongoing,” “outlook,” “plan,” “potential,” “predict,” “probable,” “project,” “seek,” “should,” “target” “view,” “will,” or “would,” or the negative thereof or other variations thereon or comparable terminology, although not all forward-looking statements contain these words. These statements reflect the Company’s reasonable judgment with respect to future events and are subject to risks, uncertainties and other factors, many of which have outcomes difficult to predict and may be outside our control, that could cause actual results or outcomes to differ materially from those in the forward-looking statements. Such risks and statements include, but are not limited to, risks relating to the merger, including risks arising from the diversion of management’s attention from the Company’s ongoing business operations, an increase in the amount of costs, fees and expenses and other charges related to the merger agreement or the merger, the outcome of any litigation that the Company or Deako may become subject to relating to the merger, the extent of, and the time necessary to obtain, any regulatory approvals that may be required for completion of the merger, risks of disruption to the Company’s business as a result of the public announcement of the merger, the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement or other agreements relating to the merger, an inability to complete the merger in a timely manner or at all, including due to a failure of any condition to the closing of the merger to be satisfied or waived by the applicable party, a decline in the market price for the Company’s common stock if the merger is not completed, risks that the merger disrupts current plans and operations of the Company or Deako and potential difficulties in Company or Deako employee retention as a result of the merger, the Company’s ability to pay the interest and principal on the promissory notes to be issued in connection with the merger, and the ability to implement business plans, forecasts and other expectations after the completion of the merger, realize the intended benefits of the merger, and identify and realize additional opportunities following the merger. Such risks and uncertainties also include statements relating to the Company’s ability to successfully launch, commercialize, develop additional features and achieve market acceptance of its products and technologies and integrate its products and technologies with third-party platforms or technologies; the Company’s ability to expand its market presence and control the market following the merger with Deako; the Company’s ability to achieve positive cash flows; the Company’s efforts and ability to drive the adoption of its products and technologies as a standard feature, including their use in homes, hotels, offices and cruise ships; the Company’s ability to capture market share; the Company’s estimates of its potential addressable market and demand for its products and technologies; the Company’s ability to raise additional capital to support its operations as needed, which may not be available on acceptable terms or at all; the Company’s ability to continue as a going concern; the Company’s ability to execute on any sales and licensing or other strategic opportunities; the possibility that any of the Company’s products will become National Electrical Code (NEC)-code or otherwise code mandatory in any jurisdiction, or that any of the Company’s current or future products or technologies will be adopted by any state, country, or municipality, within any specific timeframe or at all; risks arising from mergers, acquisitions, joint ventures and other collaborations; the Company’s ability to attract and retain key executives and qualified personnel; guidance provided by management, which may differ from the Company’s actual operating results; the potential impact of unstable market and economic conditions on the Company’s business, financial condition, and stock price; and other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including its periodic reports on Form 10-K and Form 10-Q. There can be no assurance as to any of the foregoing matters. Any forward-looking statement speaks only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by U.S. federal securities laws. 

Investor Relations Contacts:

Jeff Ramson
PCG Advisory
[email protected]

Ronald A. Both
Encore Investor Relations
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/035fa895-2b5b-4bec-a3ee-faf9e5904c61